Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B3ce312e7e981683dbbdbf7bd1fe2cd30> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B3ce312e7e981683dbbdbf7bd1fe2cd30 NCIT_P378 "NCI" @default.
- B3ce312e7e981683dbbdbf7bd1fe2cd30 type Axiom @default.
- B3ce312e7e981683dbbdbf7bd1fe2cd30 annotatedProperty IAO_0000115 @default.
- B3ce312e7e981683dbbdbf7bd1fe2cd30 annotatedSource NCIT_C81058 @default.
- B3ce312e7e981683dbbdbf7bd1fe2cd30 annotatedTarget "The anhydrous form of gadofosveset, an injectable, intravascular, amphiphilic gadolinium-based contrast agent (GBCA) used with magnetic resonance angiography (MRA) imaging. Gadofosveset is a stable gadolinium diethylenetriaminepentaacetic acid (Gd-DTPA) chelate derivative with a diphenylcyclohexylphosphate group. Upon injection, gadofosveset binds reversibly to endogenous serum albumin which increases its intravascular retention time compared to non-protein binding contrast agents. The serum albumin binding also increases T1-relaxivity of gadofosveset. This produces an increase in signal intensity of blood, thereby enhancing the visualization of blood vessels upon MRA and may aid in the diagnosis of certain blood vessels and heart disorders." @default.